Another group also regarded mPRα as a key marker of impaired prognosis for invasive breast cancer, and mPRα enhanced MMP-9 expression in the process of spreading to regional lymph nodes via the PI3K/Akt pathway [12]. This evidence concerns the gene MMP9 and invasive breast carcinoma.